Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sofinnova Capital X investment portfolio
Sofinnova Capital X has made numerous investments in companies such as Myricx Pharma, Purespring Therapeutics, and T-Therapeutics within the Healthcare & Life Sciences sector.
vc
Portfolio
4
Team
0
Portfolio (4)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Ensocell Ltd Ensocell Ltd is a biotechnology company that develops next‑generation precision biologic therapies for autoimmune and fibrotic diseases, using its single‑cell genomics‑based Ensight platform and AI‑driven computational tools. | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-03-07 |
| Myricx Pharma Limited Myricx Pharma Limited is a UK biotechnology company developing a novel class of antibody‑drug conjugate payloads that inhibit N‑myristoyltransferases for the treatment of cancer, targeting the oncology market. | Healthcare & Life Sciences | London | Confirmed | 2025-07-02 |
Shareholding changes (7)
Sofinnova Capital X's positions across portfolio companies2026
- SERIES A SHARES 8,938,546 → 15,999,998
- SERIES A 109,336,105 → 0
- SERIES A-2 0 → 75,016,334
- SERIES A-1 0 → 96,473,034